Overview: Glucose Tolerance Test Pregnancy Basal TestIntroduction: The Glucose Tolerance Test Pregnancy Basal Test measures baseline glucose during pregnancy to diagnose gestational diabetes, preventing complications. Aligned with 2023 ACOG guidelines, it uses spectrophotometry for high sensitivity, aiding in pregnancy screening. This test is critical for establishing a fasting baseline in the OGTT, guiding diagnosis, management, and improving outcomes in biochemistry for pregnant patients.
Other Names: GTT Preg Basal Assay, Basal Glucose Pregnancy Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Basal glucose testing for pregnancy began in the 1960s. The OGTT was standardized in the 1980s, with spectrophotometry refinements in the 1990s.
Purpose: Diagnoses gestational diabetes, guides management, and monitors baseline glucose levels in pregnant patients to prevent complications.
Test Parameters: 1. Glucose (Basal Pregnancy)
Pretest Condition: Fasting for 10-12 hours required. Collect plasma or serum before glucose load. Report symptoms like fatigue or thirst, and list medications.
Specimen: 2-4 mL plasma (NaF) or 2-5 mL serum (SST). Centrifuge within 1 hour. Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fatigue, thirst, or history of gestational diabetes. Include pregnancy stage, current medications, and family history of diabetes.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for diabetes management.
Procedural Considerations: Uses spectrophotometry to measure baseline glucose levels before OGTT. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Non-fasting, hemolysis, or medications (e.g., corticosteroids) can affect results. Stress may alter glucose levels.
Clinical Significance: Elevated baseline glucose levels suggest gestational diabetes, prompting further OGTT testing. Normal levels provide a reference for subsequent measurements.
Specialist Consultation: Consult an obstetrician or endocrinologist for result interpretation and pregnancy management.
Additional Supporting Tests: 1-hour or 2-hour OGTT, HbA1c, or ultrasound to confirm gestational diabetes and assess fetal health.
Test Limitations: Baseline results alone are insufficient for diagnosis. Clinical correlation and multi-point OGTT are needed.
References: ACOG Gestational Diabetes Guidelines, 2023; Obstetrics & Gynecology, Metzger BE, 2022.
